Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Background Due to the increased prevalence of diabetes-associated complications of the eye like diabetic retinopathy and cataract, the need for a novel therapeutic agent is urgent. Due to the advantages that the polyphenolic compounds enjoy in diabetes and associated complications, we postulated that Taxifolin (TXF), a poly-phenolic flavanol, could show anti-retinopathic and anti-cataract effect in diabetes-induced rats. Methods TXF at a dose of 10, 25, and 50 mg/kg was given by oral route to STZ mediated diabetic rats for a time period of 10 weeks. The opacity of lens was studied after every 7 days of treatment till 10 weeks; evaluation of the severity of cataract and changes in the histology of lens as well as retina was done. Tissue homogenates of lens isolated after the end of the study were evaluated for markers of oxidative stress, levels of aldose reductase, p38MAPK, VEGF, and ERK1/2. Results Outcomes suggested that TXF improved retinopathy and cataract in diabetes-induced rats. The treatment of TXF also improved the status of oxidative stress and inhibited the levels of p38MAPK, VEGF, and ERK1/2. The treatment also improved the lens opacity in diabetic rats. The results suggest that the protective effect of TXF against cataract and retinopathy may be due to the anti-oxidative potential of TXF and its inhibiting effect on VEGF, ERK1/2, p38MAPK, and aldose reductase. Conclusion The study confirms that TXF is a potential candidate showing a protective effect against diab…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In an in vivo study, Taxifolin was reported to act protectively against cataract in a rat model, by suppressing ERK1/2 and p38 [ 210 ]”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [210]
Citations
Cites
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
Ohkawa, H., Ohishi, N., & Yagi, K. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90738-3 · Cited by 29,297
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Selenium: Biochemical Role as a Component of Glutathione Peroxidase
Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., & Hoekstra, W. G. (1973) · Science · doi:10.1126/science.179.4073.588 · Cited by 7,809
A simple method for clinical assay of superoxide dismutase.
Sun, Y., Oberley, L. W., & Li, Y. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.3.497 · Cited by 4,504
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
Halliwell, B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,941
A simple method for determination of serum catalase activity and revision of reference range
Góth, L. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90067-m · Cited by 2,385
Oxidative Stress and Diabetic Retinopathy
Kowluru, R. A., & Chan, P.-S. (2007) · Journal of Diabetes Research · doi:10.1155/2007/43603 · Cited by 746
Mullarkey, C. J., Edelstein, D., & Brownlee, M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80875-7 · Cited by 690
Onions: A Source of Unique Dietary Flavonoids
Slimestad, R., Fossen, T., & Vågen, I. M. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0712503 · Cited by 624
Contribution of Polyol Pathway to Diabetes-Induced Oxidative Stress
Chung, S. S. M., Ho, E. C. M., Lam, K. S. L., & Chung, S. K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077408.15865.06 · Cited by 609
Research works printed but not linked: 2
- Xie X.; Feng J.; Kang Z.; Zhang S.; Zhang L.; Zhang Y.; Li X.; Tang Y.; Taxifolin protects RPE cells against oxidative stress-induced apoptosis. Mol Vis 2017,23,520-528
- Stefek M.; Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip Toxicol 2011,4(2),69-77 · DOI
Cited by
Pharmacological basis and new insights of taxifolin: A comprehensive review
Das, A., Baidya, R., Chakraborty, T., Samanta, A. K., & Roy, S. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112004 · Cited by 245
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Thakur, S., Gupta, S. K., Ali, V., Singh, P., & Verma, M. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01343-5 · Cited by 174
Recent advances in the treatment and delivery system of diabetic retinopathy
Wang, Z., Zhang, N., Lin, P., Xing, Y., & Yang, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1347864 · Cited by 88
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“In an in vivo study, Taxifolin was reported to act protectively against cataract in a rat model, by suppressing ERK1/2 and p38 [210].”
BackgroundAlgefare, A. I. (2022) · Life · doi:10.3390/life12081150 · Cited by 47
Metadata
- Authors
- Liu, F., Ma, Y., & Xu, Y.
- Affiliations
- Dalian Medical University (CN)
- Corresponding author
- Xu, Yanli
- Venue
- Endocrine, Metabolic & Immune Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2020-05-18
- Volume
- 20
- Issue
- 4
- Pages
- 599-608
- ISSN
- 1871-5303 (ISSN-L)
- OpenAlex
- W2982561660
- Cited by
- 26
- References
- 54
- Citations by year
- 2025: 5 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 1
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Metabolic & Immune Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Aldose Reductase and Taurine
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- taxifolin, diabetic cataract, diabetic retinopathy, streptozotocin-induced diabetes, aldose reductase, oxidative stress, MAPK signaling, p38 MAPK, ERK1/2, vascular endothelial growth factor, lens opacity, flavan-3-ols, polyphenols, diabetic eye complications
- MeSH terms
- Aldehyde Reductase, Animals, Cataract, Diabetes Mellitus, Experimental, Diabetic Retinopathy, Dose-Response Relationship, Drug, Male, Quercetin, Streptozocin, Rats, Wistar, Oxidative Stress, MAP Kinase Signaling System, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway. https://app.cochat.ai/papers/10.2174/1871530319666191018122821
- The paper
- Liu, F., Ma, Y., & Xu, Y. (2020). Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy in STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress, and MAPK Signaling Pathway. Endocrine, Metabolic & Immune Disorders - Drug Targets. https://doi.org/10.2174/1871530319666191018122821
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.